IGF1R and cancer: Mechanistically, IGF1R blockade stimulated a STAT3-dependent increase in autocrine IGF2 production by cancer cells, which recruited macrophages and fibroblasts, leading to the production of CXCL8 and proangiogenetic and prometastatic actions [136].